Digital Therapeutics Market to Reach $7.83 Bn, Globally by 2025 at 20.5% CAGR—Allied Market Research
A new report by Allied Market Research shows that the field of digital therapeutics has a bright future.
Increasing penetration of smartphones and tablets, and the rising incidence of chronic diseases are expected to boost the growth of the global digital therapeutics market. In addition, increasing awareness about the benefits of digital therapeutics such as low healthcare expenditure, improved patient and doctor communication, and efficient management of patients’ health supplements the market’s growth.
This is good news for companies like Propeller Health, a McKesson Ventures portfolio company, whose place in that market is defined by its digital inhaler monitor and a health platform that is used by patients, physicians, and healthcare organizations in the U.S., Europe, and Asia.
According to Allied, the digital therapeutics market stood at $1.75 billion and is expected to reach $7.83 billion by 2025, registering a CAGR of 20.5% from 2018 to 2025. The company’s report offers an in-depth analysis of the industry by closely monitoring the market trends, drivers and opportunities, top investment pockets, key growth strategies, and competitive landscape.
Allied Market Research believes that the segment of the market creating applications to fight obesity will grow the fastest, but the software segment will also remain dominant over the next five years.
As for the fastest growing region, the company believes that will be the Asia-Pacific region, due to rapid improvements in healthcare infrastructure and increasing penetration of smartphones in developing countries such as India and China. North America is forecast to remain the dominant segment through the next five years, contributing more than 41% of the total market share due to large numbers of new product launches and favorable reimbursement scenarios in the U.S.
The key market players analyzed in the report include Propeller Health, Proteus Digital Health, WellDoc, Inc.; Livongo Health; Twine Health; Noom, Inc.; Omada Health, Inc.; 2Morrow, Inc.; Canary Health, Inc.; and Medtronic Plc. These companies have adopted strategies such as product launches, partnerships, mergers and acquisitions, joint ventures, and collaborations to gain a strong foothold in the industry.
Read the full article and download the report here.